NCT04296565 · Phase 4 · ACTIVE NOT RECRUITING

Water-based Activity to Enhance Recall in Veterans

This trial tests whether combining water-based exercise with a cognitive training program improves memory in veterans who have amnestic Mild Cognitive Impairment (aMCI). Participants do an aquatic exercise phase first, then a structured brain-training program. It is a Phase 4 trial, meaning the individual approaches are already established — this is testing how well they work together in a specific population.

Eligibility criteria

Inclusion Criteria:
* Veterans, aged 50 to 90, of any racial or ethnic group
* Diagnosis of single or multi-domain amnestic MCI using criteria per National Institute on Aging/Alzheimer's Association Guidelines
* Available informant for completion of the Clinical Dementia Rating Scale
* Visual and auditory acuity to allow neuropsychological testing
* Willingness to participate in clinical trial for 14 months (8-month treatment phase, 6-month no-contact follow-up phase)
* Musculoskeletal illness or injury (i.e., osteoporosis, degenerative disc or joint disease, arthritis, obesity)
* Approval by Primary Care Provider to participate in water-based physical exercise
Exclusion Criteria:
Psychiatric Exclusions
* Current, uncontrolled severe psychiatric disorder, such as Bipolar I, Schizophrenia, or Major Depressive Disorder as determined by the Mini International Neuropsychiatric Interview (MINI)
* Diagnosis of dementia, Clinical Dementia Rating Scale (CDR) > 0.5; modified Hachinksi score 4; or delirium. Those Veterans with scores indicative of dementia (CDR > 0.5, modified Hachinksi 4) will be referred to the Memory Disorders Clinic at VAPAHCS for a full diagnostic work-up
Medical Exclusions
* History of neurological (e.g., multiple sclerosis, seizure disorder, stroke,) or system illness affecting CNS function (e.g., liver failure, kidney failure, congestive heart failure, systemic cancer)
* Acute illness or unstable chronic illness, e.g., history of severe liver disease (cirrhosis, esophageal varices, ascites, portal hypertension, hepatic encephalopathy)
* Current severe cardiac disease (e.g., uncontrolled atrial fibrillation, defined as mean 24 hour heart rate >85 beats/min, or 24 hour maximal ventricular rate >150 beats/min; uncontrolled ventricular arrhythmias, defined as recurrent ventricular tachycardia >3 beats in succession, or 24 hour PVC count >20%; active pericarditis or myocarditis; Class III/IV heart failure and / or ejection fraction \< 20%; thrombophlebitis; pulmonary disease with a drop in O2 Sat with exercise to 90% without oxygen; embolism within past 6 months)
* Inability to participate in an exercise stress test
* Inability to read, verbalize understanding and voluntarily sign the Informed Consent

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-08-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials